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was used as an internal control.
RESULTS Results showed that tanshinone IIA could protect H9c2 cells
from H2O2-induced cell death concentration-dependently. MiR-133
was involved in tanshinone IIA action. Decreases of miR-133 expres-
sion induced by increasing concentration of H2O2 could be completely
reversed by tanshinone IIA treatment. Inhibition of miR-133 function
by transfection of speciﬁc inhibitor abolished the cardioprotective
effects of tanshinone IIA against H2O2-induced cell death. Further-
more, our results also showed that tanshinone IIA could activate Akt
kinase by phosphorylation at serine 473. We furtherly determined the
Bcl-2 protein levels by western blot and found that tanshinone IIA
could completely reverse the decreases of Bcl-2 protein induced by
H2O2; but the effect of tanshinone IIA on Bcl-2 protein in oxidative
environment was suppressed by PI3K inhibitor, wortmannin, which
indicated that tanshinone IIA exerted cardioprotective effects against
H2O2-induced cell death through the activation of PI3K/Akt
signal transduction pathway and consequent upregulation of Bcl-2
expression.
CONCLUSIONS The present study indicates that tanshinone IIA is a
promising natural cardio-protective agent.
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OBJECTIVES To investigate the differences of cardiac energy meta-
bolism between left and right ventricle in the monocmtaline (MCT)
induced pulmonary arterial hypertension(PAH) rats.
METHODS PAH was induced by a single subcutaneous injection of
MCT (50 mg/kg) in rats, who developed right heart failure eventually.
At the same time, control group was injected with normal saline. MCT-
PAH rats were randomly divided into three groups according to the
treatment of MCT: MCT-2week, 3week, 4week group (MCT-2w, 3w,
4w). At the end of study, the hemodynamics and right ventricular
hypertrophy were compared in each group. The expression levels of
proliferating cell nuclear antigen (PCNA) and TdT-mediated dUTP
nick end labeling (TUNEL) were detected between left and right
ventricular myocardial cells. The differences of genes expression from
the glycolytic key candidate genes were screened between two
ventricles.
RESULTS After MCT injection for three weeks, mean pulmonary
arterial pressure, right ventricular systolic pressure and right ven-
tricular hypertrophy index were signiﬁcantly increased. The
morphology and structure were changed obviously in left and right
ventricular myocardial cells . Proliferation and apoptotic resistance
of myocardial cells were markedly increased compared with control
group. The expression of HK1 mRNA began to rise in right ventricle
of MCT-3w group, which was obviously earlier than left ventricle
(MCT-4w group). In the MCT-4w group, the expression of HK2
(hexokinase 2), PDHa1 (pyruvate dehydrogenase complex a1), LDHA
(lactate dehydrogenase A) mRNA was signiﬁcantly increased in
left ventricle, while the expression of LDHA only were up-regulated
in right ventricle. The HK1 mRNA expression was further conﬁrmed
by the expression of HK1 protein and immunohistochemistry
analysis.
CONCLUSIONS Energy metabolic shift occurred in the left and right
ventricles in PAH. Up-regulated expression of HK1 appeared earlier in
right ventricle than left ventricle. Interference of glycolysis of right
ventricle may be a novel target of PAH in the future.
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Effect of Rosuvastatin on Vascular Remodeling and Vascular Reaction of
Spontaneously Hypertension Rats
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OBJECTIVES To observe the effect of rosuvastatin on remodel and
vascular reaction of aorta from spontaneously hypertension rats
(SHR).METHODS SHR and Wister-Kyoto (WKY) rats were randomly divided
into：WKY control group; SHR treated with rosuvastatin 6.25 mg/
(kg/day); SHR treated with rosuvastatin 12.5 mg/(kg/day); rosuvasta-
tin 25 mg/(kg/day); SHR control group. Therapy continued for 8
weeks. Tail systolic blood pressure was weekly measured . At the end
of this study, aorta was moved rapidly. A part of aorta was ﬁxed with
4% paraformaldehyde to observe the vascular remodeling by HE stain.
The vascular reaction of aorta to different drugs was measured in
vitro.
RESULTS Compared with WKY, the systolic blood pressure was
higher, and vessel lumen diameter (L) decreased, while media thick-
ness (M) and M/L increased in SHR. The contractions to Phe, KCl in
aorta were increased in SHR than in WKY. The relaxation to Ach
decreased in SHR, but there was no difference of relaxation to SNP.
Treatment with rosuvastatin induced a reduction in systolic blood
pressure; increasing in L and decrease in M and M/L. Rosuvastatin
reduced the contraction of aorta to Phe and KCl; increased the
relaxation of aorta to Ach, but had no effect on the relaxation to SNP.
CONCLUSIONS The antihypertensive effect of rosuvastatin in SHR
was accompanued by protect on endothelial function: retarding
the remodeling of aorta; improving the vascular reaction to different
vasomotors, resuming the balance of relaxation and contraction.GW26-e4479
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OBJECTIVES The present study aimed to deﬁne whether sulforaph-
ane (SFN) protects from type 2 diabetic cardiomyopathy (DCM)
entirely through Nrf2.
METHODS 8 weeks of Nrf2-knockout (KO) and wild-types (WT, C57BL/
6J) mice were used to induce a type 2 diabetes (T2DM), by feeding
high-fat diet (HFD) for 3 months to induce insulin resistance and then
injecting one dose of streptozotocin (STZ, 100 mg/kg body-weight) to
induce hyperglycemia. Age-matched control mice were fed a normal
diet (ND) for the same period. Both T2DM and control mice were
treated with or without SFN at 0.5 mg/kg ﬁve days a week for 4
months along with continual feeding with either HFD or ND diet,
respectively. Cardiac oxidative damage, hypertrophy and ﬁbrosis
were assessed by western blot, real-time qPCR and histopathological
examination.
RESULTS SFN prevented diabetes-increased cardiac oxidative dam-
age (increased accumulation of 3-nitrotyrosine and 4-hydrox-
ynonenal), hypertrophy (increased the ratio of heart weight to tibia
length, b-MHC and atrial natriuretic peptide mRNA expression and
wheat germ agglutinin staining) and ﬁbrosis (increased the accu-
mulation of collagen) along with increase in Nrf2 expressions in the
WT mice. However, Nrf2-KO diabetic mice suffered from greater
cardiac damage and had more severe pathological alterations in the
heart. SFN cardiac protection was completely lost in Nrf2-KO dia-
betic mice.
CONCLUSIONS The present study demonstrated for the ﬁrst time that
Nrf2 entirely mediates SFN’s prevention of HFD / STZ-induced type 2
diabetic cardiomyopathy.GW26-e4609
Trimetazidine Attenuates Cardiac Remodeling Via Suppression AKT
Signaling Pathway
Zheng Yang, Qizhu Tang
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OBJECTIVES Trimetazidine (TMZ) is widely used in the therapy of
myocardial ischemia. Recent studies suggest that additional TMZ
treatment may be able to improve the systolic-diastolic function in
heart failure patients. But the effects and underlying mechanisms of
TMZ in cardiac remodeling are still unclear. The purpose of this study
is to estimate the effects of TMZ in cardiac remodeling and try to
explore the underlying mechanisms.
METHODS In our study, C57BL/6 mice (male, 8 to 10 weeks, 23.5 -
27.5 g weight) were subjected to aortic banding (AB) operation or
Sham as control. After operation the mice were gavaged with TMZ
(20mg/kg) or Placebo for 8 weeks. Then, echocardiography and
Pressure-Volume detection were used in the assessment of cardiac
